Bengt Ljung
AstraZeneca R&D
Research Area CV/GI
Mölndal S 431 83 Mölndal
Sweden
Name/email consistency: high
- AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats. Ljung, B., Bamberg, K., Dahllöf, B., Kjellstedt, A., Oakes, N.D., Ostling, J., Svensson, L., Camejo, G. J. Lipid Res. (2002)